3GD7
Crystal structure of human NBD2 complexed with N6-Phenylethyl-ATP (P-ATP)
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B, C, D (A, B, C, D) | Fusion complex of Cystic fibrosis transmembrane conductance regulator, residues 1193-1427 and Maltose/maltodextrin import ATP-binding protein malK, residues 219-371 | polymer | 390 | 43518.8 | 4 | UniProt (P13569) UniProt (P68187) Pfam (PF00005) Pfam (PF08402) | Homo sapiens (human bacteria) | CFTR, cAMP-dependent chloride channel, ATP-binding cassette transporter sub-family C member 7 |
| 2 | E, F, G, H (A, B, C, D) | N-(2-phenylethyl)adenosine 5'-(tetrahydrogen triphosphate) | non-polymer | 611.3 | 4 | Chemie (B44) | |||
| 3 | I, J, K, L (A, B, C, D) | water | water | 18.0 | 254 | Chemie (HOH) |
Sequence modifications
A, B, C, D: 1193 - 1427 (UniProt: P13569)
A, B, C, D: 1428 - 1580 (UniProt: P68187)
| PDB | External Database | Details |
|---|---|---|
| Ser 1191 | - | expression tag |
| Leu 1192 | - | expression tag |
| Glu 1280 | Gln 1280 | engineered mutation |
| Asn 1307 | Tyr 1307 | engineered mutation |
| Ala 1308 | Glu 1308 | engineered mutation |
| Ala 1309 | Gln 1309 | engineered mutation |
| His 1310 | Trp 1310 | engineered mutation |
| Ala 1402 | His 1402 | engineered mutation |
| Asp 1411 | Gln 1411 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 4 |
| Total formula weight | 174075.1 | |
| Non-Polymers* | Number of molecules | 4 |
| Total formula weight | 2445.3 | |
| All* | Total formula weight | 176520.4 |






